BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 26117320)

  • 1. Epigenetic regulation of Keap1-Nrf2 signaling.
    Guo Y; Yu S; Zhang C; Kong AN
    Free Radic Biol Med; 2015 Nov; 88(Pt B):337-349. PubMed ID: 26117320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.
    Richardson BG; Jain AD; Speltz TE; Moore TW
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2261-8. PubMed ID: 25937010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.
    Karapetian RN; Evstafieva AG; Abaeva IS; Chichkova NV; Filonov GS; Rubtsov YP; Sukhacheva EA; Melnikov SV; Schneider U; Wanker EE; Vartapetian AB
    Mol Cell Biol; 2005 Feb; 25(3):1089-99. PubMed ID: 15657435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2: friend or foe for chemoprevention?
    Kensler TW; Wakabayashi N
    Carcinogenesis; 2010 Jan; 31(1):90-9. PubMed ID: 19793802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.
    Deshmukh P; Unni S; Krishnappa G; Padmanabhan B
    Biophys Rev; 2017 Feb; 9(1):41-56. PubMed ID: 28510041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer.
    Chen F; Xiao M; Hu S; Wang M
    Front Oncol; 2024; 14():1381467. PubMed ID: 38634043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BET-ting on Nrf2: How Nrf2 Signaling can Influence the Therapeutic Activities of BET Protein Inhibitors.
    Chatterjee N; Bohmann D
    Bioessays; 2018 May; 40(5):e1800007. PubMed ID: 29603290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of
    Fabrizio FP; Sparaneo A; Gorgoglione G; Battista P; Centra F; Delli Muti F; Trombetta D; Centonza A; Graziano P; Rossi A; Fazio VM; Muscarella LA
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KEAP1/NRF2 Signaling Pathway in Keratinization.
    Ishitsuka Y; Ogawa T; Roop D
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32823937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Nrf2 signaling pathways in the role of bladder cancer: From signal network to targeted therapy.
    Wu L; Hu Z; Song XF; Liao YJ; Xiahou JH; Li Y; Zhang ZH
    Biomed Pharmacother; 2024 May; 176():116829. PubMed ID: 38820972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the Keap1-Nrf2 system.
    Suzuki T; Yamamoto M
    Free Radic Biol Med; 2015 Nov; 88(Pt B):93-100. PubMed ID: 26117331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complexity of the Nrf2 pathway: beyond the antioxidant response.
    Huang Y; Li W; Su ZY; Kong AN
    J Nutr Biochem; 2015 Dec; 26(12):1401-13. PubMed ID: 26419687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Nrf2 in cell proliferation and differentiation.
    Murakami S; Motohashi H
    Free Radic Biol Med; 2015 Nov; 88(Pt B):168-178. PubMed ID: 26119783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
    Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p62 links autophagy and Nrf2 signaling.
    Jiang T; Harder B; Rojo de la Vega M; Wong PK; Chapman E; Zhang DD
    Free Radic Biol Med; 2015 Nov; 88(Pt B):199-204. PubMed ID: 26117325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keap1-Nrf2 signalling in pancreatic cancer.
    Hayes AJ; Skouras C; Haugk B; Charnley RM
    Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
    Lu MC; Ji JA; Jiang ZY; You QD
    Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of the Keap1-Nrf2 system for gene and cell therapy.
    Kanninen KM; Pomeshchik Y; Leinonen H; Malm T; Koistinaho J; Levonen AL
    Free Radic Biol Med; 2015 Nov; 88(Pt B):350-361. PubMed ID: 26164630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity.
    Dodson M; Redmann M; Rajasekaran NS; Darley-Usmar V; Zhang J
    Biochem J; 2015 Aug; 469(3):347-55. PubMed ID: 26205490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Keap1-Nrf2 signaling: The role of epigenetics.
    Cheng D; Wu R; Guo Y; Kong AN
    Curr Opin Toxicol; 2016 Dec; 1():134-138. PubMed ID: 29057383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.